Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
This grant supports efforts to prevent and control parasitic infections in the U.S. using proven, evidence-based strategies.
Funder: Centers for Disease Control - NCEZID
Due Dates: July 3, 2026 (optional letter of intent) | July 17, 2026 (full application, 11:59 p.m. ET)
Funding Amounts: Total program funding: $23,750,000 | Expected awards: 11 | Annual award per applicant: up to $1,250,000 (varies by component) | Project period: up to 5 years
Summary: Funds evidence-based public health prevention and control activities to reduce the burden of parasitic infections in the United States, focusing on Chagas disease, soil-transmitted helminths, and other domestic parasitic diseases.
Key Information: Applicants may apply to only one component (A, B, or C); research activities are not supported.
Description
This opportunity supports cooperative agreements to reduce the impact of specific parasitic infections in the U.S. through public health practices and disease control strategies. The program targets three main areas: Chagas disease, soil-transmitted helminths (STH), and other parasitic diseases of domestic concern (excluding malaria, amoebiasis, cryptosporidiosis, and giardiasis). The goal is to enhance provider and community awareness, improve surveillance and diagnostic capacity, implement evidence-based interventions, and ultimately decrease morbidity and mortality related to these infections.
Applicants must select and apply for only one of three components:
- Component A: Improve healthcare provider knowledge, increase testing, and expand best practices for Chagas disease.
- Component B: Strengthen surveillance and control of soil-transmitted helminths in historically affected areas of the Southeastern U.S.
- Component C: Advance prevention, control, and health education for other domestically relevant parasitic diseases (e.g., cyclosporiasis, cysticercosis, echinococcosis, leishmaniasis, lymphatic filariasis, toxoplasmosis).
The program emphasizes alignment with CDC priorities, evidence-based strategies, and broad public health impact.
